 | • レポートコード：MRC2Q12-18921 • 出版社/出版日：QYResearch / 2022年12月 • レポート形態：英文、PDF、93ページ • 納品方法：Eメール（納期：3営業日） • 産業分類：医薬品＆医療 |
| Single User | ￥725,200 (USD4,900) | ▷ お問い合わせ |
| Enterprise License | ￥1,450,400 (USD9,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 新型コロナウイルス感染症とロシア・ウクライナ戦争の影響により、Casヌクレアーゼのグローバル市場は 2022にxxxドルと推定され、2028年までにxxxドルの規模に達し、2022年から2028年の予測期間中にxxx%のCAGRで成長すると予測されています。 Casヌクレアーゼのアメリカ市場は、2023年から2028年の予測期間中にxxx%のCAGRで、2022年xxxドルから2028年xxxドルに達すると推定されています。 Casヌクレアーゼの中国市場は、2023年から2028年の予測期間中にxxx%のCAGRで、2022年xxxドルから2028年xxxドルに達すると推定されています。 Casヌクレアーゼのヨーロッパ市場は、2023年から2028年の予測期間中にxxx%のCAGRで、2022年xxxドルから2028年xxxドルに達すると推定されています。 生産面において、本レポートは2017年から2022年までのCasヌクレアーゼの生産、成長率、メーカー別市場シェア、地域別市場シェア、および2028年までの予測を調査しています。販売面において、本レポートは2017年から2022年までの地域別、企業別、タイプ別、アプリケーション別のCasヌクレアーゼの売上および2028年までの予測に焦点を当てています。 Casヌクレアーゼのグローバル主要企業には、GenScript、Aldevron、Agilent、Horizon Discovery、Integrated DNA Technologies, Inc.、Thermo Fisher Scientificなどがあります。2021年、世界のトップ5プレイヤーは売上ベースで約xxx％の市場シェアを占めています。 Casヌクレアーゼ市場は、タイプとアプリケーションによって区分されます。世界のCasヌクレアーゼ市場のプレーヤー、利害関係者、およびその他の参加者は、当レポートを有益なリソースとして使用することで優位に立つことができます。セグメント分析は、2017年～2028年期間のタイプ別およびアプリケーション別の販売量、売上、予測に焦点を当てています。 【タイプ別セグメント】 Cas3、Cas9、Cas10 【アプリケーション別セグメント】 細胞モデル、疾患診断、汎用サイズスクリーニング、遺伝子治療、その他 【掲載地域】 北米：アメリカ、カナダ ヨーロッパ：ドイツ、フランス、イギリス、イタリア、ロシア アジア太平洋：日本、中国、韓国、インド、オーストラリア、台湾、インドネシア、タイ、マレーシア 中南米：メキシコ、ブラジル、アルゼンチン 中東・アフリカ：トルコ、サウジアラビア、UAE 【目次（一部）】 ・調査の範囲 - Casヌクレアーゼ製品概要 - タイプ別市場（Cas3、Cas9、Cas10） - アプリケーション別市場（細胞モデル、疾患診断、汎用サイズスクリーニング、遺伝子治療、その他） - 調査の目的 ・エグゼクティブサマリー - 世界のCasヌクレアーゼ販売量予測2017-2028 - 世界のCasヌクレアーゼ売上予測2017-2028 - Casヌクレアーゼの地域別販売量 - Casヌクレアーゼの地域別売上 - 北米市場 - ヨーロッパ市場 - アジア太平洋市場 - 中南米市場 - 中東・アフリカ市場 ・メーカーの競争状況 - 主要メーカー別Casヌクレアーゼ販売量 - 主要メーカー別Casヌクレアーゼ売上 - 主要メーカー別Casヌクレアーゼ価格 - 競争状況の分析 - 企業M&A動向 ・タイプ別市場規模（Cas3、Cas9、Cas10） - Casヌクレアーゼのタイプ別販売量 - Casヌクレアーゼのタイプ別売上 - Casヌクレアーゼのタイプ別価格 ・アプリケーション別市場規模（細胞モデル、疾患診断、汎用サイズスクリーニング、遺伝子治療、その他） - Casヌクレアーゼのアプリケーション別販売量 - Casヌクレアーゼのアプリケーション別売上 - Casヌクレアーゼのアプリケーション別価格 ・北米市場 - 北米のCasヌクレアーゼ市場規模（タイプ別、アプリケーション別） - 主要国別のCasヌクレアーゼ市場規模（アメリカ、カナダ） ・ヨーロッパ市場 - ヨーロッパのCasヌクレアーゼ市場規模（タイプ別、アプリケーション別） - 主要国別のCasヌクレアーゼ市場規模（ドイツ、フランス、イギリス、イタリア、ロシア） ・アジア太平洋市場 - アジア太平洋のCasヌクレアーゼ市場規模（タイプ別、アプリケーション別） - 主要国別のCasヌクレアーゼ市場規模（日本、中国、韓国、インド、オーストラリア、台湾、インドネシア、タイ、マレーシア） ・中南米市場 - 中南米のCasヌクレアーゼ市場規模（タイプ別、アプリケーション別） - 主要国別のCasヌクレアーゼ市場規模（メキシコ、ブラジル、アルゼンチン） ・中東・アフリカ市場 - 中東・アフリカのCasヌクレアーゼ市場規模（タイプ別、アプリケーション別） - 主要国別のCasヌクレアーゼ市場規模（トルコ、サウジアラビア） ・企業情報 GenScript、Aldevron、Agilent、Horizon Discovery、Integrated DNA Technologies, Inc.、Thermo Fisher Scientific ・産業チェーン及び販売チャネル分析 - Casヌクレアーゼの産業チェーン分析 - Casヌクレアーゼの原材料 - Casヌクレアーゼの生産プロセス - Casヌクレアーゼの販売及びマーケティング - Casヌクレアーゼの主要顧客 ・マーケットドライバー、機会、課題、リスク要因分析 - Casヌクレアーゼの産業動向 - Casヌクレアーゼのマーケットドライバー - Casヌクレアーゼの課題 - Casヌクレアーゼの阻害要因 ・主な調査結果 |
Report Overview
Due to the COVID-19 pandemic and Russia-Ukraine War Influence, the global market for Cas Nuclease estimated at US$ million in the year 2022, is projected to reach a revised size of US$ million by 2028, growing at a CAGR of % during the forecast period 2022-2028.
The USA market for Cas Nuclease is estimated to increase from $ million in 2022 to reach $ million by 2028, at a CAGR of % during the forecast period of 2023 through 2028.
The China market for Cas Nuclease is estimated to increase from $ million in 2022 to reach $ million by 2028, at a CAGR of % during the forecast period of 2023 through 2028.
The Europe market for Cas Nuclease is estimated to increase from $ million in 2022 to reach $ million by 2028, at a CAGR of % during the forecast period of 2023 through 2028.
The global key companies of Cas Nuclease include GenScript, Aldevron, Agilent, Horizon Discovery, Integrated DNA Technologies, Inc. and Thermo Fisher Scientific, etc. In 2021, the global top five players had a share approximately % in terms of revenue.
Report Scope
This latest report researches the industry structure, revenue and gross margin. Major players’ headquarters, market shares, industry ranking and profiles are presented. The primary and secondary research is done in order to access up-to-date government regulations, market information and industry data. Data were collected from the Cas Nuclease companies, distributors, end users, industry associations, governments’ industry bureaus, industry publications, industry experts, third party database, and our in-house databases.
This report also includes a discussion of the major players across each regional Cas Nuclease market. Further, it explains the major drivers and regional dynamics of the global Cas Nuclease market and current trends within the industry.
Key Companies Covered
In this section of the report, the researchers have done a comprehensive analysis of the prominent players operating and the strategies they are focusing on to combat the intense competition. Company profiles and market share analysis of the prominent players are also provided in this section. Additionally, the specialists have done an all-encompassing analysis of each player. They have also provided reliable revenue, market share and rank data of the companies for the period 2017-2022. With the assistance of this report, key players, stakeholders, and other participants will be able to stay abreast of the recent and upcoming developments in the business, further enabling them to make efficient choices. Mentioned below are the prime players taken into account in this research report:
GenScript
Aldevron
Agilent
Horizon Discovery
Integrated DNA Technologies, Inc.
Thermo Fisher Scientific
Market Segments
This report has explored the key segments: by Type and by Application. The lucrativeness and growth potential have been looked into by the industry experts in this report. This report also provides revenue forecast data by type and by application segments based on value for the period 2017-2028.
Cas Nuclease Segment by Type
Cas3
Cas9
Cas10
Cas Nuclease Segment by Application
Cell Model
Disease Diagnosis
Generic Size Screening
Gene Therapy
Others
Key Regions & Countries
This section of the report provides key insights regarding various regions and the key players operating in each region. Economic, social, environmental, technological, and political factors have been taken into consideration while assessing the growth of the particular region/country. The readers will also get their hands on the value data of each region and country for the period 2017-2028.
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
COVID-19 and Russia-Ukraine War Influence Analysis
The readers in the section will understand how the Cas Nuclease market scenario changed across the globe during the pandemic, post-pandemic and Russia-Ukraine War. The study is done keeping in view the changes in aspects such as demand, consumption, transportation, consumer behavior, supply chain management, export and import, and production. The industry experts have also highlighted the key factors that will help create opportunities for players and stabilize the overall industry in the years to come.
Report Includes:
This report presents an overview of global market for Cas Nuclease market size. Analyses of the global market trends, with historic market revenue data for 2017 – 2021, estimates for 2022, and projections of CAGR through 2028.
This report researches the key producers of Cas Nuclease, also provides the revenue of main regions and countries. Highlights of the upcoming market potential for Cas Nuclease, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Cas Nuclease revenue, market share and industry ranking of main companies, data from 2017 to 2022. Identification of the major stakeholders in the global Cas Nuclease market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by type and by application, revenue, and growth rate, from 2017 to 2028. Evaluation and forecast the market size for Cas Nuclease revenue, projected growth trends, production technology, application and end-user industry.
Descriptive company profiles of the major global players, including GenScript, Aldevron, Agilent, Horizon Discovery, Integrated DNA Technologies, Inc. and Thermo Fisher Scientific, etc.
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Revenue of Cas Nuclease in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. This section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Cas Nuclease companies’ competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments according to product types, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments according to application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: North America by type, by application and by country, revenue for each segment.
Chapter 7: Europe by type, by application and by country, revenue for each segment.
Chapter 8: Asia Pacific by type, by application and by country/region, revenue for each segment.
Chapter 9: Latin America by type, by application and by country, revenue for each segment.
Chapter 10: Middle East and Africa by type, by application and by country, revenue for each segment.
Chapter 11: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Cas Nuclease revenue, gross margin, and recent development, etc.
Chapter 12: Analyst’s Viewpoints/Conclusions
1 Report Business Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Cas Nuclease Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
1.2.2 Cas3
1.2.3 Cas9
1.2.4 Cas10
1.3 Market by Application
1.3.1 Global Cas Nuclease Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 Cell Model
1.3.3 Disease Diagnosis
1.3.4 Generic Size Screening
1.3.5 Gene Therapy
1.3.6 Others
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Cas Nuclease Market Perspective (2017-2028)
2.2 Cas Nuclease Growth Trends by Region
2.2.1 Cas Nuclease Market Size by Region: 2017 VS 2021 VS 2028
2.2.2 Cas Nuclease Historic Market Size by Region (2017-2022)
2.2.3 Cas Nuclease Forecasted Market Size by Region (2023-2028)
2.3 Cas Nuclease Market Dynamics
2.3.1 Cas Nuclease Industry Trends
2.3.2 Cas Nuclease Market Drivers
2.3.3 Cas Nuclease Market Challenges
2.3.4 Cas Nuclease Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Cas Nuclease Players by Revenue
3.1.1 Global Top Cas Nuclease Players by Revenue (2017-2022)
3.1.2 Global Cas Nuclease Revenue Market Share by Players (2017-2022)
3.2 Global Cas Nuclease Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Cas Nuclease Revenue
3.4 Global Cas Nuclease Market Concentration Ratio
3.4.1 Global Cas Nuclease Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Cas Nuclease Revenue in 2021
3.5 Cas Nuclease Key Players Head office and Area Served
3.6 Key Players Cas Nuclease Product Solution and Service
3.7 Date of Enter into Cas Nuclease Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Cas Nuclease Breakdown Data by Type
4.1 Global Cas Nuclease Historic Market Size by Type (2017-2022)
4.2 Global Cas Nuclease Forecasted Market Size by Type (2023-2028)
5 Cas Nuclease Breakdown Data by Application
5.1 Global Cas Nuclease Historic Market Size by Application (2017-2022)
5.2 Global Cas Nuclease Forecasted Market Size by Application (2023-2028)
6 North America
6.1 North America Cas Nuclease Market Size (2017-2028)
6.2 North America Cas Nuclease Market Size by Type
6.2.1 North America Cas Nuclease Market Size by Type (2017-2022)
6.2.2 North America Cas Nuclease Market Size by Type (2023-2028)
6.2.3 North America Cas Nuclease Market Share by Type (2017-2028)
6.3 North America Cas Nuclease Market Size by Application
6.3.1 North America Cas Nuclease Market Size by Application (2017-2022)
6.3.2 North America Cas Nuclease Market Size by Application (2023-2028)
6.3.3 North America Cas Nuclease Market Share by Application (2017-2028)
6.4 North America Cas Nuclease Market Size by Country
6.4.1 North America Cas Nuclease Market Size by Country (2017-2022)
6.4.2 North America Cas Nuclease Market Size by Country (2023-2028)
6.4.3 United States
6.4.4 Canada
7 Europe
7.1 Europe Cas Nuclease Market Size (2017-2028)
7.2 Europe Cas Nuclease Market Size by Type
7.2.1 Europe Cas Nuclease Market Size by Type (2017-2022)
7.2.2 Europe Cas Nuclease Market Size by Type (2023-2028)
7.2.3 Europe Cas Nuclease Market Share by Type (2017-2028)
7.3 Europe Cas Nuclease Market Size by Application
7.3.1 Europe Cas Nuclease Market Size by Application (2017-2022)
7.3.2 Europe Cas Nuclease Market Size by Application (2023-2028)
7.3.3 Europe Cas Nuclease Market Share by Application (2017-2028)
7.4 Europe Cas Nuclease Market Size by Country
7.4.1 Europe Cas Nuclease Market Size by Country (2017-2022)
7.4.2 Europe Cas Nuclease Market Size by Country (2023-2028)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Cas Nuclease Market Size (2017-2028)
8.2 Asia-Pacific Cas Nuclease Market Size by Type
8.2.1 Asia-Pacific Cas Nuclease Market Size by Type (2017-2022)
8.2.2 Asia-Pacific Cas Nuclease Market Size by Type (2023-2028)
8.2.3 Asia-Pacific Cas Nuclease Market Share by Type (2017-2028)
8.3 Asia-Pacific Cas Nuclease Market Size by Application
8.3.1 Asia-Pacific Cas Nuclease Market Size by Application (2017-2022)
8.3.2 Asia-Pacific Cas Nuclease Market Size by Application (2023-2028)
8.3.3 Asia-Pacific Cas Nuclease Market Share by Application (2017-2028)
8.4 Asia-Pacific Cas Nuclease Market Size by Region
8.4.1 Asia-Pacific Cas Nuclease Market Size by Region (2017-2022)
8.4.2 Asia-Pacific Cas Nuclease Market Size by Region (2023-2028)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America Cas Nuclease Market Size (2017-2028)
9.2 Latin America Cas Nuclease Market Size by Type
9.2.1 Latin America Cas Nuclease Market Size by Type (2017-2022)
9.2.2 Latin America Cas Nuclease Market Size by Type (2023-2028)
9.2.3 Latin America Cas Nuclease Market Share by Type (2017-2028)
9.3 Latin America Cas Nuclease Market Size by Application
9.3.1 Latin America Cas Nuclease Market Size by Application (2017-2022)
9.3.2 Latin America Cas Nuclease Market Size by Application (2023-2028)
9.3.3 Latin America Cas Nuclease Market Share by Application (2017-2028)
9.4 Latin America Cas Nuclease Market Size by Country
9.4.1 Latin America Cas Nuclease Market Size by Country (2017-2022)
9.4.2 Latin America Cas Nuclease Market Size by Country (2023-2028)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Cas Nuclease Market Size (2017-2028)
10.2 Middle East & Africa Cas Nuclease Market Size by Type
10.2.1 Middle East & Africa Cas Nuclease Market Size by Type (2017-2022)
10.2.2 Middle East & Africa Cas Nuclease Market Size by Type (2023-2028)
10.2.3 Middle East & Africa Cas Nuclease Market Share by Type (2017-2028)
10.3 Middle East & Africa Cas Nuclease Market Size by Application
10.3.1 Middle East & Africa Cas Nuclease Market Size by Application (2017-2022)
10.3.2 Middle East & Africa Cas Nuclease Market Size by Application (2023-2028)
10.3.3 Middle East & Africa Cas Nuclease Market Share by Application (2017-2028)
10.4 Middle East & Africa Cas Nuclease Market Size by Country
10.4.1 Middle East & Africa Cas Nuclease Market Size by Country (2017-2022)
10.4.2 Middle East & Africa Cas Nuclease Market Size by Country (2023-2028)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 GenScript
11.1.1 GenScript Company Details
11.1.2 GenScript Business Overview
11.1.3 GenScript Cas Nuclease Introduction
11.1.4 GenScript Revenue in Cas Nuclease Business (2017-2022)
11.1.5 GenScript Recent Developments
11.2 Aldevron
11.2.1 Aldevron Company Details
11.2.2 Aldevron Business Overview
11.2.3 Aldevron Cas Nuclease Introduction
11.2.4 Aldevron Revenue in Cas Nuclease Business (2017-2022)
11.2.5 Aldevron Recent Developments
11.3 Agilent
11.3.1 Agilent Company Details
11.3.2 Agilent Business Overview
11.3.3 Agilent Cas Nuclease Introduction
11.3.4 Agilent Revenue in Cas Nuclease Business (2017-2022)
11.3.5 Agilent Recent Developments
11.4 Horizon Discovery
11.4.1 Horizon Discovery Company Details
11.4.2 Horizon Discovery Business Overview
11.4.3 Horizon Discovery Cas Nuclease Introduction
11.4.4 Horizon Discovery Revenue in Cas Nuclease Business (2017-2022)
11.4.5 Horizon Discovery Recent Developments
11.5 Integrated DNA Technologies, Inc.
11.5.1 Integrated DNA Technologies, Inc. Company Details
11.5.2 Integrated DNA Technologies, Inc. Business Overview
11.5.3 Integrated DNA Technologies, Inc. Cas Nuclease Introduction
11.5.4 Integrated DNA Technologies, Inc. Revenue in Cas Nuclease Business (2017-2022)
11.5.5 Integrated DNA Technologies, Inc. Recent Developments
11.6 Thermo Fisher Scientific
11.6.1 Thermo Fisher Scientific Company Details
11.6.2 Thermo Fisher Scientific Business Overview
11.6.3 Thermo Fisher Scientific Cas Nuclease Introduction
11.6.4 Thermo Fisher Scientific Revenue in Cas Nuclease Business (2017-2022)
11.6.5 Thermo Fisher Scientific Recent Developments
12 Analyst’s Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Author Details
13.3 Disclaimer